You Jian, Zhou Jialin, Zhou Min, Liu Yang, Robertson J David, Liang Dong, Van Pelt Carolyn, Li Chun
Department of Cancer Systems Imaging, Unit 59, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Part Fibre Toxicol. 2014 May 30;11:26. doi: 10.1186/1743-8977-11-26.
OBJECTIVE: Gold nanoparticles have attracted enormous interest as potential theranostic agents. However, little is known about the long-term elimination and systemic toxicity of gold nanoparticles in the literature. Hollow gold nanospheres (HAuNS) is a class of photothermal conducting agent that have shown promises in photoacoustic imaging, photothermal ablation therapy, and drug delivery. It's very necessary to make clear the biosafety of HAuNS for its further application. METHODS: We investigated the cytotoxicity, complement activation, and platelet aggregation of polyethylene glycol (PEG)-coated HAuNS (PEG-HAuNS, average diameter of 63 nm) in vitro and their pharmacokinetics, biodistribution, organ elimination, hematology, clinical chemistry, acute toxicity, and chronic toxicity in mice. RESULTS: PEG-HAuNS did not induce detectable activation of the complement system and did not induce detectable platelet aggregation. The blood half-life of PEG-HAuNS in mice was 8.19 ± 1.4 hr. The single effective dose of PEG-HAuNS in photothermal ablation therapy was determined to be 12.5 mg/kg. PEG-HAuNS caused no adverse effects after 10 daily intravenous injections over a 2-week period at a dose of 12.5 mg/kg per injection (accumulated dose: 125 mg/kg). Quantitative analysis of the muscle, liver, spleen, and kidney revealed that the levels of Au decreased 45.2%, 28.6%, 41.7%, and 40.8%, respectively, from day 14 to day 90 after the first intravenous injection, indicating that PEG-HAuNS was slowly cleared from these organs in mice. CONCLUSION: Our data support the use of PEG-HAuNS as a promising photothermal conducting agent.
目的:金纳米颗粒作为潜在的诊疗试剂引起了极大关注。然而,文献中关于金纳米颗粒的长期消除和全身毒性知之甚少。中空金纳米球(HAuNS)是一类光热传导剂,在光声成像、光热消融治疗和药物递送方面已显示出应用前景。明确HAuNS的生物安全性对于其进一步应用非常必要。 方法:我们研究了聚乙二醇(PEG)包覆的HAuNS(PEG-HAuNS,平均直径63nm)的体外细胞毒性、补体激活和血小板聚集情况,以及它们在小鼠体内的药代动力学、生物分布、器官清除、血液学、临床化学、急性毒性和慢性毒性。 结果:PEG-HAuNS未诱导可检测到的补体系统激活,也未诱导可检测到的血小板聚集。PEG-HAuNS在小鼠体内的血液半衰期为8.19±1.4小时。光热消融治疗中PEG-HAuNS的单次有效剂量确定为12.5mg/kg。在2周内每天静脉注射10次,每次剂量为12.5mg/kg(累积剂量:125mg/kg)后,PEG-HAuNS未产生不良反应。对肌肉、肝脏、脾脏和肾脏的定量分析显示,首次静脉注射后第14天至第90天,Au的水平分别下降了45.2%、28.6%、41.7%和40.8%,表明PEG-HAuNS在小鼠体内从这些器官中缓慢清除。 结论:我们的数据支持将PEG-HAuNS用作有前景的光热传导剂。
Part Fibre Toxicol. 2014-5-30
Biomaterials. 2009-12-24
Curr Pharm Biotechnol. 2024
Regen Biomater. 2024-10-24
Front Pharmacol. 2019-10-4
Front Cardiovasc Med. 2019-9-18
Nat Mater. 2014-2
Acc Chem Res. 2011-8-17
J Nanopart Res. 2010-9
Biomaterials. 2009-12-24